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Summary 
Nuclear transfer allows the reprogramming of somatic cells to totipotency. The cell cycle 
state of the donor and recipient cells, as well as their extent of differentiation, have each 
been cited as important determinants of reprogramming success. Here we have used 
donor and recipient cells at various cell cycle and developmental stages to investigate the 
importance of these parameters. We found that many stages of the cell cycle were 
compatible with reprogramming as long as a sufficient supply of essential nuclear factors, 
such as Brg1, were retained in the recipient cell following enucleation. Consistent with 
this conclusion, the increased efficiency of reprogramming when using donor nuclei from 
embryonic cells could be explained, at least in part, by reintroduction of embryonic 
nuclear factors along with the donor nucleus. In contrast, cell cycle synchrony between 
the donor nucleus and the recipient cell was not required at the time of transfer, as long as 
synchrony was reached by the first mitosis. Our findings demonstrate the remarkable 
flexibility of the reprogramming process and support the importance of nuclear 
transcriptional regulators as mediators of reprogramming.  
 
Introduction 
The generation of cloned animals by nuclear transfer has demonstrated that the 
differentiated state of a cell can be reprogrammed to a more embryonic character and that 
developmental potential can be fully restored (Gurdon, 1962; Wilmut et al., 1997). This 
reprogramming process has been reported to depend on the cell cycle stage of the 
recipient cell into which the nucleus is injected. Reprogramming succeeds when a variety 
of terminally differentiated nuclei are injected into an unfertilized, metaphase-oocyte 
(Eggan et al., 2004; Hochedlinger and Jaenisch, 2002). In stark contrast, when a fertilized 
zygote in interphase is used as a recipient cell, only a zygotic nucleus from another 
embryo, or the nucleus from a 2-cell stage embryo can support development (McGrath 
and Solter, 1984). When more differentiated nuclei are introduced into the zygote, 
development fails (Gao et al., 2002; McGrath and Solter, 1984; Robl et al., 1987; 
Tsunoda et al., 1987). Although this difference in reprogramming capacity between the 3 
 
oocyte and the zygote is well documented, there remains little mechanistic clarity as to 
why recipient oocytes in M-phase can support developmental reprogramming while 
zygotes in interphase cannot.  
A variety of explanations for the cell-cycle dependence of successful 
reprogramming have been proposed. Developmental failure after nuclear transfer into 
non-metaphase recipient cells has been attributed to an unidentified reprogramming 
activity that exists only in the metaphase cytoplasm of unfertilized oocytes and that is 
degraded following fertilization (Eckardt et al., 2005; Tani et al., 2003). Conversely, it 
could be that following fertilization an inhibitor of reprogramming becomes expressed. 
These models are attractive as they could explain why zygotes function as recipients for 
totipotent nuclei, but do not support development when more differentiated nuclei are 
used.  
It has also been considered that the developmental failure of embryos generated 
by somatic cell nuclear transfer into zygotes could be due to the amount of time available 
for reprogramming.  In the mouse, zygotic genome activation (ZGA) occurs at the two-
cell stage.  Following zygotic nuclear transfer there might be insufficient time to prepare 
a differentiated nucleus for the genome-wide activation of embryonic gene expression 
(Boiani et al., 2002; Campbell et al., 1996b; Kikyo and Wolffe, 2000; Solter, 2000). 
Similar to the remodeling of the sperm after fertilization, the somatic cell nucleus would 
need to be biochemically remodeled in the unfertilized oocyte (Rideout et al., 2001).  
Additionally, it has been suggested that developmental failures after zygote 
nuclear transfer could result from incompatibilities between the recipient and donor cell-
cycles that in turn lead to chromosome damage (Wakayama et al., 2000). In this model, 
cellular processes that are ongoing in the interphase zygote, such as DNA synthesis, 
might preclude the successful incorporation of incoming donor chromosomes. If this 
were the case, the arrested nature of the meiotic oocyte might allow for synchronization 
of the embryonic and somatic cell cycles, allowing successful incorporation of the 
differentiated donor cell chromosomes. 
Interestingly, we have recently demonstrated that the interphase zygote regains its 
capacity to reprogram a differentiated somatic nucleus when it enters into the first 
embryonic mitosis (Egli et al., 2007), and regains it again when it enters the mitosis 4 
 
between the two and 4-cell stage (Egli et al., 2009). These experiments have lead us to 
propose a new model in which reprogramming factors are not destroyed following 
fertilization, but are instead sequestered in the nucleus during interphase and widely 
distributed in the cytoplasm during mitosis (Egli et al., 2008). This model predicts that 
enucleation of a recipient zygote in interphase would deplete factors required for 
reprogramming (Egli et al., 2008; Egli et al., 2007) and that depletion of these factors, 
rather than other difficulties, might be the cause of developmental arrest. 
To test our model, and to investigate other proposed mechanisms for failures in 
reprogramming, we have performed nuclear transfer using donor and recipient cells of 
various cell cycle states and developmental identities. From these studies we conclude 
that the retention of critical embryonic nuclear factors within the reconstructed embryo is 
indeed one of the most significant determinant of whether reprogramming succeeds.  
Beyond this, we find there is remarkable flexibility in the parameters for successful 
nuclear transfer.  
 
Materials and Methods 
Mice and cell lines 
BDF1 mice used as zygote donors were obtained from Charles River laboratories. 
Transgenic ES expressed the H2B-cherry fusion gene under the control of the combined 
CMV-chicken beta actin promoter (pCAGGS-H2B-cherry). Tail tip fibroblasts used for 
nuclear transfer were obtained from adult B6jcBA-Tg (Pou5fI-EGFP)2Mnn/J mice. H2B-
GFP transgenic mice were made by integration of pCAGGS-H2B-GFP puro
r plasmid into 
V6.5 mouse ES cells and injection into blastocysts followed by embryo transfer into 
pseudopregnant recipient females. ES cells were synchronized in mitosis using 0.1μg/ml 
nocodazole. 
 
Manipulations 
Chromosome transfer into mouse zygotes in mitosis 5 
 
Manipulations were performed as described previously (Egli et al., 2007), with some 
modifications. To minimize the amount of spindle material removed, mitotic zygotes 
were released from the nocodazole block (0.1μg/ml), for 1-3 minutes at 37deg. to induce 
the formation of a small prometaphase spindle. Zygotes were then manipulated in drops 
containing 0.02 -0.03μg/ml nocodazole, either at room temperature or at 37deg. to 
remove the zygotic genome. We observed that low concentrations of nocodazole slow 
down mitotic progression, but do not depolymerize the spindle, and reduce the amount of 
spindle material removed from the zygote.  If placed directly into low nocodazole 
concentrations at interphase, zygotes arrested in early prometaphase as seen by the 
disorganized configuration of chromosomes and a weak signal of microtubule 
birefringence (see Fig. S4 in the Supplementary Material). Such arrested zygotes have a 
spindle visible by light microscopy. In the presence of MG-132 as previously used (Egli 
et al., 2007), zygotes proceed from prometaphase to metaphase within approx. 30-60 
minutes and assemble a very robust spindle that becomes increasingly more difficult to 
remove. Unlike MG-132 that has a toxic effect upon prolonged exposure, nocodazole is 
not toxic and embryos can be incubated in nocodazole after transfer for recovery for an 
additional 30 min. This method allows working with a single nocodazole concentration to 
both arrest and manipulate zygotes throughout the experiment. The use of nocodazole 
alone instead of in combination with Mg-132 resulted in cleavage with less 
fragmentation.  
 
Nuclear transfer into zygotes in interphase  
Nuclear transfer was carried out 24-28h post hCG. Zygotes were incubated in 0.5μg/ml 
nocodazole and 5-10 μg/ml cytochalasinB for complete and specific enucleation. Specific 
enucleation was done using a conical needle with an opening of approx. 2μm, according 
to (Greda et al., 2006). ES cell genomes were directly injected, while blastomere nuclei 
were fused by electrical pulse 1.6kV/cm in fusion medium using the LF101 device.  
To transfer mitotic zygotic genomes into zygotes enucleated in interphase, mitotic 
zygotes were selected within a cohort of zygotes and their genome was transferred into a 
zygote enucleated in interphase from the same cohort (28-33h post hCG).  6 
 
To break the nuclear envelope of one of the two interphase nuclei of the zygote, 
the nucleus was removed, broken with a brief piezo-electric pulse and then reinjected into 
the same zygote.  
For isolation of mitotic genomes from 8-cell stage embryos, they were incubated 
in nocodazole for mitotic arrest at approx. 60h post hCG for 5 hours. Within 20-30min 
after the release from the nocodazole arrest, mitotic spindles formed that could be 
aspirated into a needle with a 10μm diameter and injected into an interphase recipient 
zygote.  
 
Immunohistochemistry 
Zygotes and preimplantation stage embryos were fixed in 4% paraformaldehyde over 
night at 4°C, permeabilized in PBS with 0.5% Triton-X100 (PBS/T) for 20min., blocked 
in blocking solution consisting of 0.1% PBS/T with 10% FBS over night at 4°C, 
incubated in primary antibody at 4°C in blocking solution, then washed for 1h at room 
temperature in 0.1% PBS/T, incubated with secondary conjugated antibody in 0.1% 
PBS/T at room temperature for 1h, washed for 1h, stained with Hoechst 33342 or Draq5 
for 5-10 minutes and used for confocal imaging. Oct4 antibody (Santa Cruz, sc5279) and 
Cdx-2 antibody (Biogenex) was used at a concentration of 1:200, and BRG1 antibody 
(Santa Cruz sc-10768) was used at a concentration of 1:50. Conditions were maintained 
between different samples. Relative quantification of BRG1 staining was done by 
integrating pixel density in Adobe Photoshop. For BrdU incorporation, embryos were 
incubated in BrdU (Amersham Cell Proliferation Kit) at 32h post hCG, after the 
completion of zygotic mitosis. Embryos were fixed with 4% PFA at the 2-cell stage, 45h 
post hCG, incubated in BrdU primary antibody and DNAse according to the 
manufacturer’s instructions.  
 
Microarray analysis 
Groups of 20-30 embryos were used for RNA isolation. Total RNA was isolated using 
PicoPure RNA isolation kit (Molecular Devices), and RNA was amplified by two rounds 
of T7 transcription using the Illumina TotalPrep RNA Amplification Kit. Amplified RNA 
was hybridized to the to Illumina® Sentrix Mouse Expression BeadChip® RefSeq 8 v2.0 7 
 
or v1.1 and read by the Illumina Bead Array Reader. Analysis was done using the 
Illumina Genome Studio Program. Genome-less embryos were generated by removal of 
the zygotic genome in mitosis followed by mitotic exit stimulated by purvalanolA and 6-
DMAP. Primary data will be available at http://www.ncbi.nlm.nih.gov/geo/. 
 
Results 
Interphase zygotes are suitable as recipient cells 
Our observation that nuclear transfer into mitotic oocytes and mitotic zygotes succeeds 
but that nuclear transfer into interphase zygotes fails, has re-raised the question of why 
interphase recpient cells are not suitable for reprogramming (Egli et al., 2007). We 
initially considered the hypothesis that ongoing processes within the interphase recipient 
cell damage the incoming donor chromosomes, resulting in compromised development 
(Wakayama 1999).  
If it were correct that ongoing processes in the cytoplasm of the interphase zygote 
invariably damaged incoming donor chromosomes, then it would stand to reason, that 
this damage to the donor chromosomes would occur even if the recipient cell nucleus 
were not removed. To test whether an intact interphase zygote could accept incoming 
donor chromosomes, we injected mitotic ES cell chromosomes and observed whether the 
resulting embryos could develop to the blastocyst stage.  
We opted to use ES donor cells as they could be efficiently micro-manipulated 
and were reliably arrested in mitosis using nocodazole. By synchronizing the donor cell 
population in one phase of the cell cycle, we could more easily isolate and study the 
importance of the recipient’s cell cycle status. In these experiments, we tracked the 
recipient and donor cell chromosomes by using recipient zygotes that expressed the 
histone H2B-green fluorescent fusion protein (H2B-GFP) and donor cells that expressed 
the H2B-cherry red fluorescent protein (Fig. 1A,B). Thus recipient cell chromosomes 
were fluorescent green and incoming donor chromosomes fluorescent red.  
Following injection of mitotic donor chromosomes into interphase zygotes, we 
observed that the incoming chromosomes were not organized into a new nucleus and 
instead were maintained as condensed chromatin separate from the two parental 8 
 
pronuclei (see Fig. S1 in the supplementary material). Despite this asynchronous 
configuration of the chromosomes, the zygotic cell-cycle proceeded normally. These 
tetraploid embryos entered the first mitosis and underwent the first cleavage division with 
the same timing as un-manipulated control embryos. At 31h post hCG, 16 of 28 nuclear 
transfer zygotes (57%) and 23 of 44 (52%) control zygotes had entered mitosis and 
undergone cell division (Fig. 1 D-G). Following nuclear transfer, interphase zygotes 
cleaved and developed to the blastocyst stage very efficiently (Fig. 1 H,I). As these 
tetraploid embryos contained both the donor and recipient chromosomes, they expressed 
both H2B-GFP and H2B-cherry (Fig.1 G-I). These results demonstrate that contrary to 
previous suggestion (Wakayama et al., 1999), the interphase zygote can successfully 
incorporate donor cell chromosomes following nuclear transfer.  
 
Our observations demonstrate that the interphase recipient zygote does not always 
destroy the donor chromosomes, as was previously observed with somatic interphase 
donor nuclei (Wakayama et al., 2000). In those cases, it is possible that chromosomal 
damage to the interphase-donor genomes might have been due to a failure to complete 
DNA replication prior to entry into mitosis. Consistent with these results, we found that 
interphase ES cells injected into interphase zygotes most commonly lead to cell cycle 
delay and developmental arrest (see Table S1 in the supplementary material). In contrast, 
when we used mitotic donor chromatin, DNA replication was already complete at the 
time of transfer. This may have allowed the asynchronous cell cycles of the donor and 
recipient cells to become synchronized at the first mitosis, enabling normal chromosome 
segregation to proceed.  
Despite the successful incorporation of mitotic donor chromosomes into an intact 
interphase zygote, when mitotic ES cell chromosomes were injected into enucleated 
zygotes, development still failed (Fig. 1E, supplemental Table 1). These results suggest 
that something about the interphase enucleation process renders the interphase zygote 
incapable of supporting reprogramming.  
 
Interphase pro-nuclei contain reprogramming activities 9 
 
Our observation that interphase zygotes can successfully incorporate incoming donor 
chromosomes suggested that the difficulties in using these recipient cells might be related 
to the means by which, or time at which, they were enucleated. To determine whether this 
was the case, we transferred mitotic donor chromosomes into the interphase zygote and 
then removed the recipient chromosomes at various times to note the effect. We primarily 
studied two time points for extraction of the mitotic chromosomes. Following mitotic 
chromosome transfer, we either enucleated the recipient zygote before the end of the first 
interphase, or we waited 1 to 5 hours longer and removed the condensed recipient cell 
chromosomes after entry into the first mitosis.  
When mitotic chromosomes were injected into the interphase zygote and recipient 
cell enucleation was subsequently performed in interphase, development failed at the 2-
cell stage (Fig. 1E) (see Table S1 in the Supplementary Material). 
To confirm that recipient cell enucleation in interphase was indeed the cause of 
developmental arrest, we again performed mitotic chromosome injection during 
interphase but then waited for the transferred embryos to enter the first mitosis, and only 
then removed the recipient cell chromosomes. So that we could be certain we had 
distinguished the donor and recipient chromosomes from one another in these 
experiments, we prevented congregation of the chromosomes onto the first metaphase 
spindle by incubating nuclear transfer embryos in the presence of nocodazole and used 
the fluorescently tagged histones described above to allow for visualization of donor and 
recipient chromosomes (Fig. 1D). 
Interestingly, we observed that in 20/20 nuclear transfer zygotes, tagged histones 
of both colors began to exchange between the donor and recipient cell chromosomes.  
This suggested that rapid exchange of core histones was taking place in a reciprocal 
manner. This exchange was reminiscent of the dynamic localization of histone H2B in 
mouse ES cells described previously (Meshorer et al., 2006). It could be that this 
incorporation of zygotic histones into donor-cell chromatin contributes to the 
reprogramming process.   
Despite the considerable histone exchange we observed, it was always possible 
(20/20 zygotes) to unambiguously distinguish between the recipient and donor 
chromosomes based on the relative intensity of their fluorescence (Fig. 2D). The donor 10 
 
genome always showed higher relative red fluorescence, while the recipient genome 
always had higher relative green fluorescence (20/20 zygotes). This difference in 
fluorescence intensity allowed for the specific and reliable removal of only the zygotic 
recipient cell chromosomes, while leaving behind the donor chromosomes (Fig. 1J,K). 
Following extraction of the recipient cell chromosomes in mitosis, nocodazole was 
removed from the culture medium to allow a spindle to assemble around the donor 
chromosomes. Following spindle assembly, cleavage proceeded normally. In the newly 
formed interphase nuclei of the resulting 2-cell embryos, a strong H2B-GFP signal was 
detected (Fig. 1L) suggesting that histones present in the cytoplasm of the zygote 
continued to be incorporated into the newly introduced donor cell chromatin.  
We found that preimplantation development of embryos created in this way, by 
interphase chromosome transfer and subsequent mitotic extraction of the recipient 
chromosomes, was very efficient (Fig. 1L-O) and allowed the derivation of ES cell lines 
from the resulting blastocysts (Supplementary Fig. 2A-C)). During the development of 
these nuclear transfer embryos, H2B-GFP green fluorescence was gradually lost from the 
embryo, while H2B-cherry red fluorescence began to increase after the 4-cell stage. This 
loss of green fluorescence and increase in red fluorescence indicated that the zygotic 
chromosomes carrying the H2B-GFP transgene had indeed been successfully removed 
and that only the donor cell chromosomes remained (Fig. 1M,N).  
These experiments confirm that chromosome transfer into an interphase recipient 
cell is indeed acceptable and that incoming chromosomes are not damaged, even after 
removal of the recipient cell chromosomes. However, if reprogramming and development 
are to succeed, the recipient cell chromosomes must either not be removed at all or 
removed only in mitosis.  
 
Normal chromosome segregation and DNA replication after interphase enucleation 
We next sought to determine why nuclear transfer embryos arrest following interphase 
enucleation but not following mitotic enucleation. One possible explanation for these 
failures is that when zygotes are enucleated in interphase, factors required for either 
development or reprogramming are removed. If this were the case, then it must be that 
these factors are not removed or depleted when zygotes are enucleated in mitosis. This is 11 
 
a reasonable proposal as many protein factors within the cell localize specifically to the 
nucleus in interphase but are more widely distributed in the cytoplasm during mitosis 
(Egli et al., 2008). These factors could include but are not necessarily limited to 
transcriptional regulators, components of the DNA replication machinery and factors 
involved in chromosome segregation or cytokinesis.  Depletion of any one of these 
important cellular components might be sufficient to lead to the developmental arrest that 
we, and others, have observed.  
We first considered the possibility that enucleation during interphase could be 
preventing further development by depleting limiting components of the spindle 
apparatus or cell division machinery. Undergoing cell division in the presence of 
insufficient quantities of these components could lead to improper chromosome 
segregation, chromosome damage, wholesale aneuploidy, or developmental arrest. To 
test this model, zygotes were enucleated in interphase, mitotic ES cell chromosomes 
transferred and the resulting cell division observed. Following nuclear transfer, these 
embryos entered mitosis with relatively normal kinetics. Control zygotes entered into 
mitosis within 31 hours post hCG (100%). At the same time point, 61 of 66 nuclear 
transfer zygotes (92%) were also mitotic.  
To further test the ability of these nuclear transfer embryos to assemble a normal 
spindle, they were arrested in mitosis using nocodazole, released from the mitotic block 
and spindle formation observed. Within 45 min., 31/31 nuclear transfer zygotes, and 
30/30 control zygotes had assembled normal bipolar spindles. These spindles were 
indistinguishable from those of control zygotes both by microtubule birefringence, as 
well as by beta-tubulin immunofluorescence staining (Fig. 2 A-F).  
Similar to fertilized controls, interphase nuclear transfer zygotes proceeded from 
prometaphase through anaphase to cytokinesis within 90 minutes of release from the 
nocodazole block (Fig. 2G-I). Furthermore, there was very limited association of 
microtubules with the interphase pronuclei of the zygote, suggesting this component of 
the spindle apparatus would not be depleted by enucleation (Fig. 2D). Together, these 
results suggest that if components of the spindle assembly or cell division machinery are 
removed during interphase enucleation, there is a sufficient cytoplasmic store to allow 
normal cell-division.  12 
 
It has been demonstrated that inhibitors of DNA replication, such as aphidicolin 
can arrest mouse embryos at the two-cell stage (Spindle et al., 1985). These inhibitors 
both arrest development and interfere with subsequent zygotic genome activation. 
Therefore, it seemed reasonable that enucleation of the zygote at interphase might 
eliminate essential components of the DNA replication machinery, preventing DNA 
replication in the next interphase and therefore development beyond the two-cell stage. 
However, we observed that both control and interphase nuclear transfer embryos (12/12) 
efficiently incorporated BrdU at the 2-cell stage, demonstrating that DNA synthesis could 
still occur (Fig. 2J, K). These results suggest that interphase nuclear transfer embryos 
arrest well past S-phase entry and that it is not an inability to replicate the DNA that leads 
to the observed developmental arrest.  
 
Abnormal transcription following interphase nuclear transfer 
Because nuclear transfer embryos enucleated in interphase proceeded through 
chromosome segregation, cytokinesis and DNA replication efficiently but then invariably 
arrested before division to the 4-cell stage, we investigated whether they underwent 
normal zygotic genome activation, which would be required for their subsequent 
development.  To this end, we compared the transcriptional profile of fertilized control 
embryos with nuclear transfer embryos created using recipient zygotes enucleated in 
either interphase or in mitosis. We chose to profile embryos at the 2-cell stage because 
this is when ZGA occurs and because both types of nuclear transfer embryos efficiently 
reach the 2-cell stage, but differ in developmental potential there after. As controls, we 
profiled both types of enucleated recipient zygotes prior to transfer as well as un-
manipulated 2-cell stage embryos and the ES donor cells. 
As expected, when global gene expression patterns were compared, interphase 
zygotes clustered closely together with mitotic zygotes. In contrast, 2-cell stage embryos, 
which had undergone ZGA, had a significantly different transcriptional profile and 
clustered separately (Fig. 3A). Embryos subjected to nuclear transfer after enucleation in 
mitosis, which have high developmental potential, clustered together with control 2-cell 
stage embryos; this suggests that transcriptional reprogramming of the donor 
chromosomes had occurred. In contrast, embryos generated after enucleation in 13 
 
interphase were transcriptionally distinct from other two-cell embryos, suggesting 
abnormalities in transcription (Fig. 3A).  
The transcriptional abnormalities that followed interphase enucleation were also 
reflected in the number of genes that were upregulated during embryonic genome 
activation at the 2-cell stage. Of 13037 total transcripts that were represented on the gene 
expression array, we found 575 significantly (P=0.001) upregulated between the one and 
2-cell stages, presumably reflecting zygotic genome activation (ZGA). Interestingly, 
535/575 (93%, p=0.01) of these transcripts were also upregulated following enucleation 
in mitosis. In contrast, only 4/575 genes (0.7%, p=0.01) were properly induced in nuclear 
transfer embryos enucleated at interphase.  
Of the 575 transcripts upregulated between the one and two cell stage, 303 were 
not expressed or expressed at only low levels in the donor ES cells (Fig. 3B). These were 
therefore transcripts from genes that would presumably require transcriptional activation 
following nuclear transfer. Of these 303 transcripts, 272 (90%, p=0.01) were properly 
upregulated in nuclear transfer embryos generated by mitotic enucleation. In contrast, 
only one gene was successfully upregulated in nuclear transfer embryos after interphase 
enucleation (0.3%, Nme2), which was strikingly similar to embryos that had been 
enucleated and then allowed to develop in the absence of chromosomes (0/303 activated).  
These results indicate that the transcriptional profile of an NT embryo produced 
by mitotic enucleation is remarkably normal while the transcriptional profile of an NT 
embryo produced by interphase enucleation is abnormal and in fact, is most equivalent to 
that of an enucleated embryo with no chromosomes. This finding is consistent with the 
idea that interphase enucleation depletes the early embryo of transcriptional regulators 
that are required for proper zygotic genome activation from the donor chromosomes. It 
could be that the observed failure of germinal vesicle stage oocytes to support 
development following nuclear transfer was caused by the depletion of these same 
nuclear transcription factors (Gao et al., 2003).  
In summary, enucleated interphase zygotes were unable to reprogram the ES cell 
genome, correlating with developmental failure. In contrast, M-phase zygotes can 
efficiently transition the ES cell chromosomes to a transcriptional state similar to that of a 
2-cell stage embryo, correlating with a high developmental potential. Importantly, these 14 
 
findings rule out the model in which insufficient time for reprogramming underlies 
developmental arrest following interphase nuclear transfer (Kikyo and Wolffe, 2000). 
Even though nuclear transfer into mitotic zygotes allows less time for reprogramming, it 
is still sufficient time to enable development to proceed normally. 
 
Enucleation Depletes the Transcriptional Regulator Brg1 
Our findings thus far seemed consistent with a model in which enucleation of the 
recipient cell in interphase not only removes the chromosomes but also depletes 
transcriptional regulators that are required for reprogramming. The depletion of these 
transcription factors might then be the cause of the observed developmental failures at the 
2- cell stage. We noted that the rapid developmental arrest following interphase 
enucleation seemed strikingly similar to the preimplantation arrest of embryos that harbor 
a loss of function mutation in Brg1 (Bultman et al., 2006). We therefore considered the 
possibility that interphase enculeation was depleting the early embryo of BRG1, which is 
a required component of the Swi/SNF chromatin remodeling complex and essential for 
normal zygotic genome activation. 
We found that Brg1 could be readily detected by immunostaining in the maternal 
and paternal pronuclei of interphase zygotes, as well as in the nuclei of 2-cell stage 
embryos (Fig. 4A,B). However, when interphase zygotes were enucleated, the majority of 
Brg1 was removed from the cell (Fig. 4C). Consequently, nuclear levels of Brg1 were 
substantially lower in embryos that had arrested at the two cell stage following interphase 
enucleation; the fluorescence intensity of immuno-labeled BRG1 was reduced at least 10- 
fold (Fig. 4D, H). Although we did observe some residual Brg1 that originated from 
either RNA or cytoplasmic protein pools, the vast majority of this protein was removed 
by interphase enucleation. Thus the failure of interphase nuclear transfer embryos to 
undergo normal ZGA could be the result of depletion of the Brg1 protein and/or other 
transcriptional regulators. 
A hallmark of mitotic entry is breakdown of the nuclear envelope and dispersion 
of many nuclear factors through out the cytoplasm, which allows the two resulting 
daughter cells to inherit equal portions of nuclear components. When the localization of 
Brg1 was assessed in mitotic zygotes, we found that it too was scattered throughout the 15 
 
cytoplasm and excluded from the chromatin (Fig. 4E,F). The cell-cycle dependence of 
Brg1 localization we observed was consistent with that previously reported in somatic 
cells and in mouse oocytes, where Brg1 localizes to the interphase nucleus, but is 
dispersed in the cytoplasm during mitosis (Muchardt et al., 1996; Sun et al., 2007). As a 
result, when recipient cell chromosome extraction was performed after mitotic entry, 
Brg1 was not depleted and the resulting 2-cell embryos (Fig. 4G) had Brg1 levels 
comparable to the two-cell control embryos (Fig. 4B,H) and developed normally. Thus 
the removal of Brg1, and likely many other transcription factors, with the interphase 
nucleus correlated with developmental failure, while the retention of these factors 
correlated with normal development and successful transcriptional reprogramming. 
 
Factors required for reprogramming associate closely with chromatin in interphase 
but not in mitosis 
We next considered whether or not performing interphase enucleation via a method that 
would allow the zygote to maintain a subset of its nuclear factors would stimulate its 
capacity to develop after nuclear transfer. Recently, a novel method for interphase 
enucleation has been developed. Instead of aspirating the entire nucleus from the zygote, 
the nucleus is mechanically disrupted, and the nuclear envelope with attached chromatin 
is more specifically removed (see Fig. S3A in the supplementary material) (Greda et al., 
2006). This disruption of the nuclear envelope might be expected to release some nuclear 
components into the cytoplasm, allowing them to be left behind after removal of the 
chromatin. 
We removed the chromosomes from interphase zygotes by either conventional 
enucleation or by mechanically disrupting the nucleus prior to removing the chromatin. 
We then transferred nuclei or mitotic chromosomes from various donor cell types into 
these recipients and compared the extent and efficiency of development (Fig. 5A-F). As 
had been previously reported (McGrath and Solter, 1984), when 8-cell stage donor nuclei 
were injected into normally enucleated zygotes, they failed to develop. In contrast, when 
these blastomere donor nuclei were introduced into zygotes whose nuclei had been 
mechanically disrupted prior to enucleation, these embryos developed to the blastocyst 
stage (Greda et al., 2006)(Fig. 5E).  16 
 
However, when more differentiated ES cells were used as nuclear donors, 
development invariably arrested at the 2-cell stage, regardless of whether or not 
enucleation was carried out with disruption of the nuclear envelope (Fig. 5B). In these 
experiments, as before, development only proceeded when ES cell donor chromosomes 
were injected into control mitotic zygotes (Fig. 5B,G).  
The development of embryos after transfer of 8-cell stage nuclei into specifically 
enucleated interphase nuclei suggests that disruption of the nuclear envelope prior to 
enucleation releases some factors required for development. However, this release must 
not be complete as it is not sufficient to support transcriptional reprogramming of ES cell 
chromosomes.   
Consistent with this interpretation, when one of the pro-nuclear envelopes was 
disrupted by micromanipulation, a modest amount of Brg1 was released into the 
cytoplasm. However, the broken pro-nucleus still retained significant quantities of this 
protein after its removal (n=5/5) (Fig. 6). Our findings demonstrate that activities 
required for transcriptional reprogramming are in part closely associated with chromatin 
in interphase and that they are removed with the interphase chromosomes regardless of 
the enucleation method used. In contrast, these nuclear factors are not closely associated 
with mitotic chromosomes, allowing the maximal concentration of these factors to be 
retained when the recipient cell chromosomes are removed during mitosis (Fig. 5E-G).  
 
Removal of interphase nuclei depletes factors required for ZGA 
The depletion of Brg1 caused by interphase enucleation and the immediate 
developmental arrest that resulted raised the question of whether the transcriptional 
regulators depleted by interphase enucleation were specifically required for 
reprogramming or whether they are also more generally required for processes that 
facilitate preimplantation development, for instance ZGA. To distinguish between these 
two models, we transferred chromosomes from one mitotic donor zygote into a recipient 
zygote that had been enucleated in interphase. The resulting nuclear transfer embryos 
should not require reprogramming activities as the transferred chromosomes are derived 
from exactly the same cell type. However, these embryos would still be expected to 
require all activities necessary for normal preimplantation development.  17 
 
When mitotic donor chromosomes from one zygote were transferred into another 
zygote that had been enucleated in interphase, the resulting embryos invariably arrested 
at the 2-cell stage (Fig. 5D,G). These embryos formed small nuclei without the prominent 
nucleoli usually present at this stage (see Fig. S3b in the supplementary material).  
To control for these manipulations, interphase nuclei from one zygote were 
transferred into recipient zygotes enucleated in that same phase of the cell cycle. As 
expected, and previously observed, (McGrath and Solter, 1983), these control embryos 
developed very efficiently (Fig. 5F,G). Similarly, when mitotic chromosomes from a 
zygote were transferred into an interphase zygote that had been enucleated following 
nuclear disruption, the resulting embryos could develop to term, albeit at a low efficiency 
(Fig. 5D,G, see Table S2 in the Supplementary Material). Removal of chromatin in 
interphase after nuclear envelope disruption therefore depletes, but does not completely 
eliminate, factors required for development. This depletion does however severely 
compromise the ability of the zygote to reprogram more differentiated cells. 
 
Factors from embryonic nuclei can partially replace those depleted by interphase 
enucleation 
If enucleation removes factors required for normal development and reprogramming, 
then re-introduction of these factors might be expected to restore developmental 
potential. We reasoned that nuclei, but not mitotic chromosomes, of cells 
developmentally related to the zygote might provide a source of these factors. Consistent 
with this idea, we found that the nuclei of cleavage stage embryos contained high levels 
of Brg1, and that Brg1 was excluded from the condensed chromatin when these cells 
entered mitosis (Fig. 7). We isolated either nuclei or mitotic chromosomes from 8-cell 
stage blastomeres and then injected them into zygotes enucleated in interphase by the 
conventional method. Injection of the mitotic 8-cell stage chromosomes resulted in arrest 
at the 2-cell stage (Fig. 5C) while transfer of the 8-cell interphase nucleus and its 
accompanying factors allowed further development to a compacted 4-cell stage (Fig. 5E).  
To determine whether the factors in the 8-cell stage nucleus could collaborate 
with a reduced dose of zygotic nuclear factors to direct development, either nuclei or 
mitotic chromosomes from 8 cell stage blastomeres were transferred into zygotes that had 18 
 
their nuclei disrupted prior to enucleation. As previously described, when 8-cell stage 
nuclei were transferred into these cytoplasts, embryonic development to the blastocyst 
stage was observed (Fig. 5E). However, when mitotic chromosomes from the same 
blastomeres were transferred, development failed (Fig. 5C). Thus factors contained in the 
8-cell stage nucleus can partially complement the effect of losing the factors removed 
from the zygote along with the interphase nucleus.  However, this complementation is not 
complete because if the zygote pronuclei are fully removed and then replaced with a 
blastomere nucleus, development cannot proceed (see Table S2 in the supplementary 
material). Thus, the quantities of Brg1 in the 8-cell stage nucleus are either insufficient or 
it is not the only limiting factor removed along with the zygotic pronuclei.  
Discussion 
Our findings demonstrate that reprogramming activities are not degraded after 
fertilization, but persist throughout the first cell cycle in the zygote and even in 2-cell 
stage blastomeres (Egli et al., 2009). We also show that the early arrest of nuclear transfer 
embryos after interphase microinjection are not always the direct result of 
incompatibilities between the cell cycle of the zygote and the donor cell, nor a result of a 
defect in chromosome segregation during mitosis. Instead, our experiments suggest these 
phenotypes are secondary consequences of the depletion of nuclear factors caused by 
interphase enucleation.  
Our analysis here suggests that the essential nuclear factors removed by 
enucleation are transcriptional regulators required for zygotic genome activation 
and reprogramming.  It is likely that components of the DNA replication and spindle 
assembly machinery that associate with chromatin in interphase but dissociate from 
it in mitosis (Cuvier et al., 2008) are also removed with the interphase nucleus. 
However, zygotes enucleated in interphase maintain the ability to form a functional 
bi-polar spindle and to replicate their DNA, suggesting that depletion of these 
factors is not the causes for developmental arrest. Instead, failure to develop further 
is likely to be a direct consequence of the highly abnormal gene expression patterns 
we observed.  19 
 
In these studies we were surprised by the flexibility of cell cycle parameters for 
successful nuclear transfer.  Zygotes were suitable genome recipients in mitosis as well as 
in interphase and cell cycle synchrony between donor and recipient was not strictly 
required at the time of transfer. In some experiments, the mitotic donor genome was 
initially asynchronous with the interphase zygote and became synchronous only upon 
entry of the zygote into the first mitosis. With the exception of perhaps donor cells in S-
phase, there appear to be few constraints on the recipient or donor-cell cycle requirements 
for successful reprogramming (Campbell et al., 1996a).  
Our finding that reprogramming and development after nuclear transfer succeeds 
as long as nuclear components are retained is consistent with results from other 
reprogramming systems. When somatic cells are fused with either intact ES cells or 
isolated ES cell nuclei, transcriptional reprogramming of the somatic chromosomes 
occurs and stable hybrid cell lines can be established (Cowan et al., 2005; Do and 
Scholer, 2004; Tada et al., 2001). However, when ES cells were enucleated in interphase, 
they could no longer reprogram the somatic genome (Do and Scholer, 2004).  
The four reprogramming transcription factors required for the generation of iPS 
cells (Takahashi and Yamanaka, 2006), Oct4, Klf4, cMyc and Sox2, each localize to the 
nuclei of interphase ES cells. Thus, just as we have shown here, depletion of these 
nuclear factors after ES cell enucleation is a plausible explanation for the failure of 
reprogramming approaches based on cell fusion. This suggests that removal of the ES 
cell chromosomes in mitosis might result in an ES cell derived cytoplast that retained 
reprogramming potential.  
Also consistent with our model, injection of nuclei directly into the germinal 
vesicle (nucleus) of the frog oocyte results in reprogramming of transcription (Byrne et 
al., 2003), while removal of the germinal vesicle from mouse oocytes depletes the oocyte 
of reprogramming activities (Do and Scholer, 2004; Gao et al., 2002; Pralong et al., 
2005).  
All of these findings support the view that nuclear components, particularly those 
required for transcriptional regulation, are critical for reprogramming and must be 
retained in the early embryonic recipient cell if development is to proceed. Specifically 
illustrating our point, we found that the essential transcriptional regulator Brg1 is 20 
 
sequestered in the interphase nucleus of a zygote but becomes dispersed throughout the 
cytoplasm during mitosis 
We found that this cell-cycle dependent distribution of Brg1 contributed to its 
depletion when either interphase nuclei or interphase chromatin were removed from the 
recipient cell. The depletion of Brg1 was associated with failures in reprogramming and a 
developmental arrest similar to that observed in mutant embryos engineered to lack this 
protein (Bultman et al., 2006). In contrast, Brg1 protein was preserved in the cell when 
the chromatin was removed in mitosis, facilitating both development and reprogramming 
of gene expression.  
However, our experiments suggest that Brg1 is not likely to be the only factor 
depleted by interphase enucleation. Many other transcriptional regulators undergo a 
similar redistribution in mitosis and they would also be depleted by interphase 
enucleation. In interphase, transcription factors localize to the nucleus, where they are in 
intimate association with the chromatin, regulating gene expression. When cells enter 
into mitosis, gene expression becomes repressed and these proteins are dispersed through 
out the cytoplasm, allowing them to be equally inherited by each daughter cell (Egli et 
al., 2008; Gao et al., 2007; Gottesfeld and Forbes, 1997; Martinez-Balbas et al., 1995; 
Sun et al., 2007). We propose that it is the sum of these transcriptional regulators in a 
particular cell that define it’s cell-type specific gene expression pattern as well as the 
transcriptional program that is engaged after its use as a recipient cell in nuclear transfer.  
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Figure Legends 
Fig. 1.  Development after mitotic genome transfer into interphase zygotes. 
 (A) Diagram of the transfer of a mitotic ES cell genome (red) into an H2B-GFP positive 
(green) zygote in interphase. (B) Zygote immediately after transfer. (C,D) zygote in 
mitosis in the presence of nocodazole. Note the difference in intensity of green and red 
histones on the two zygotic (haploid maternal and haploid paternal (arrows), and the 
diploid ES cell genome (arrowhead). (E) Removal of zygotic nuclei before entry into 
mitosis, while still in interphase. (F) Removal of nocodazole from mitotic zygotes results 
in the assembly of both ES cell genome and zygotic genomes in a single spindle 
(schematic). (G-I) Development of tetraploid embryos with both ES cell genome and 
zygotic genome expressing both H2B-cherry and H2B-GFP. (J) removal of zygotic 
genomes. (K-N) Development of embryos after the removal of the zygotic genome. 
Images in (G-I) and (K-N) were taken with identical exposure time. (O) Development to 
the morula and blastocyst stage after genome transfer into zygotes in interphase. 
Numbers indicated the number of morulas and blastocysts of successfully transferred 
(cleaved) embryos. PB= polar body. (For detailed results see Table S1 in the 
Supplementary Material.) 
 
Fig. 2. Removal of interphase nuclei permits spindle assembly and replication in 
nuclear transfer embryos 
(A-C) Control zygotes in mitosis. (A) shortly after release from 0.4μg/ml nocodazole. 
(B), and immunocytochemistry (C). (D) Zygote in mitosis prior to removal of interphase 25 
 
nuclei, in the presence of 0.4μg/ml and 10μg/ml cytochalasinB used for enucleation. (E-
I) Mitotic progression of zygotes after removal of interphase nuclei and subsequent 
transfer of a mitotic ES cell genome. BrdU incorporation in control (J) and interphase 
nuclear transfer embryos (K). 
 
Fig. 3. Nuclear factors are required for reprogramming  
(A) Gene expression cluster analysis of nuclear transfer and control embryos: interphase 
zygotes were harvested 25-28h post hCG injection, mitotic zygotes were obtained by 
nocodazole mediated arrest until 33h post hCG. Nuclear transfer embryos (below the 
line) were allowed to the 2-cell stage and harvested 22-24h post transfer. Each datapoint 
consists of two samples. Two independent experiments (2 and 2 samples each) of ES 
cells transferred into M-phase zygotes are shown. (B) heat map of genes upregulated at 
the 2-cell stage and not expressed in the donor cell (left), or downregulated at the 2-cell 
stage and expressed in ES donor cells (right). Shown is the differential gene expression 
score relative to M-phase zygotes.  
 
Fig. 4. BRG1 is associated with chromatin in interphase zygotes and excluded in 
mitosis 
(A) A zygote in interphase. (B) 2-cell stage un-manipulated control embryo. (C) Zygote 
nucleus removed from an interphase zygote. (D) 2-cell stage embryo after enucleation in 
interphase and transfer of a mitotic ES cell genome. One of the two cells are shown at 
high magnification (note size bars). (E) M-phase zygote arrested with nocodazole. (F) 
Zygote without genome and removed nuclear material (arrow) of an M-phase zygote 
arrested in nocodazole. (G) 2-cell stage embryo after genome removal in mitosis and 
transfer of a mitotic ES cell genome. (H) Relative quantification of BRG1 nuclear 
staining. Interphase and mitosis indicate the time point of enucleation. Error bars 
represent the standard deviation of at least 3 different cells.  
 
Fig. 5. Developmental outcome is determined by the removal and transfer of 
developmental factors 26 
 
(A) Recipient zygotes are prepared either by complete enucleation in interphase, by 
breaking the nuclear envelope prior to removal of the interphase chromatin or by 
extraction of mitotic chromosomes. Each of these genome-less zygotes is transferred with 
an entire mitotic ES cell (B), or an isolated mitotic 8-cell stage genome (C), or a mitotic 
zygotic genome (D), or an 8-cell stage interphase nucleus (E) or an interphase nucleus of 
a zygote (F). The green color indicates the distribution of putative nuclear factors 
involved in preimplantation development. (G) Percentage of embryos developing to the 
morula and blastocyst stages. Numbers indicated the number of morulas and blastocysts 
of successfully transferred (cleaved) embryos. (For detailed results see Table S2 in the 
Supplementary Material.) Size bar represents 20μm. The broken lines in E, top lane, 
represent the boundaries between different blastomeres. 
 
Fig. 6. BRG1 is associated with chromatin  
(A) A zygote in interphase with a nucleus broken by micromanipulation (star*) and an 
intact pronucleus (arrow). Note the presence of BRG1 on the chromatin even in the 
broken nucleus, albeit at a lower intensity than of the intact nucleus. (B) relative 
quantification of BRG1 nuclear staining. Error bars represent the standard deviation of at 
least 3 different cells.   
 
Fig. 7. BRG1 is found in interphase nuclei of blastomeres, but not on their mitotic 
chromosomes  
Nuclei of blastomeres of a cleavage stage embryo in interphase and in mitosis (arrow). 
Again note the absence of BRG1 from mitotic chromatin.  
 
 